Additionally, genetic factors, obesity, inflammation, oxidative stress, hyperglycemia, hyperinsulinemia, cancer therapies, insulin and some oral hypoglycemic drugs appear to play a role in the crosstalk between diabetes mellitus and cancers (Figure 1). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.